Show simple item record

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study

dc.contributor.authorColomba, Een_US
dc.contributor.authorLe Teuff, Gen_US
dc.contributor.authorEisen, Ten_US
dc.contributor.authorStewart, GDen_US
dc.contributor.authorFife, Ken_US
dc.contributor.authorLarkin, Jen_US
dc.contributor.authorBiondo, Aen_US
dc.contributor.authorPickering, Len_US
dc.contributor.authorSrinivasan, Aen_US
dc.contributor.authorBoyle, Hen_US
dc.contributor.authorDerosa, Len_US
dc.contributor.authorSternberg, CNen_US
dc.contributor.authorRecine, Fen_US
dc.contributor.authorRalph, Cen_US
dc.contributor.authorSaldana, Cen_US
dc.contributor.authorBarthelemy, Pen_US
dc.contributor.authorBernhard, JCen_US
dc.contributor.authorGurney, Hen_US
dc.contributor.authorVerhoest, Gen_US
dc.contributor.authorVauleon, Een_US
dc.contributor.authorBigot, Pen_US
dc.contributor.authorBerger, Jen_US
dc.contributor.authorPfister, Cen_US
dc.contributor.authorGravis, Gen_US
dc.contributor.authorRodier, J-Men_US
dc.contributor.authorCuline, Sen_US
dc.contributor.authorCaty, Aen_US
dc.contributor.authorRolland, Fen_US
dc.contributor.authorPriou, Fen_US
dc.contributor.authorEscudier, Ben_US
dc.contributor.authorAlbiges, Len_US
dc.date.accessioned2018-02-20T12:00:24Z
dc.date.issued2017-07en_US
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403329300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9en_US
dc.identifier.citationEUROPEAN JOURNAL OF CANCER, 2017, 80 pp. 55 - 62en_US
dc.identifier.issn0959-8049en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1398
dc.identifier.eissn1879-0852en_US
dc.identifier.doi10.1016/j.ejca.2017.03.011en_US
dc.format.extent55 - 62en_US
dc.subjectNon-clear cell RCCen_US
dc.subjectChromophobe RCCen_US
dc.subjectMetastaticen_US
dc.subjectAnti-angiogenicen_US
dc.subjectVEGFen_US
dc.subjectmTORen_US
dc.titleMetastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyen_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.ejca.2017.03.011en_US
rioxxterms.licenseref.startdate2017-07en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfEUROPEAN JOURNAL OF CANCERen_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume80en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMelanoma and Kidney Canceren_US
dc.contributor.icrauthorLarkin, Jamesen_US
dc.contributor.icrauthorMarsden,en_US


Files in this item

Thumbnail
Name:
rm.PNG
Size:
63.31Kb
Format:
PNG image
Description:
Supporting information
View/Open

This item appears in the following Collection(s)

Show simple item record